Developing candidates to solve the hardest-to-treat symptoms of Pompe and Fabry disease.
| Program | Indication | Platform | Stage |
|---|---|---|---|
| ST-101 | Pompe Disease | Classical ERT | Preclinical |
| ST-102 | Pompe Disease | AAV Gene Therapy | NIH-funded Discovery |
| ST-201 | Fabry Disease | Classical ERT | Preclinical |